JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Custom and stocked solutions for COVID-19 programs.

CleanCap^®mRNA for rapid vaccine development and top-tier oligos to power diagnostic kits

CleanCap^® sets a new standard for superior mRNA translation.

Find out how CleanCap^® technology reduces cost while increasing efficiency.

Learn More

A clear path to the clinic with scalable manufacturing of mRNA, oligos, and custom reagents

TriLink BioTechnologies is expanding to a new global headquarters and state-of-the-art manufacturing campus. Our expertise is now combined with enhanced GMP capabilities to take your innovation from research to the clinic.

Learn More

About TriLink BioTechnologies

TriLink BioTechnologies, part of Maravai LifeSciences, is your CDMO for overcoming challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its patented CleanCap^® mRNA capping technology. TriLink continues to expand its cGMP and general manufacturing capacity at its new global headquarters to support mRNA, oligonucleotide & plasmid therapeutic, vaccine and diagnostic customers.